search icon
edit-img

Editas Medicine Inc, Common Stock

EDIT

NSQ

$1.83

-$0.04

(-2.14%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$135.61M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.56M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.15
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.91 L
$6.22 H
$1.83

About Editas Medicine Inc, Common Stock

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameEDITSectorS&P500
1-Week Return12.96%0.71%0.79%
1-Month Return18.06%-5.6%6.04%
3-Month Return-4.69%-11.72%-1.11%
6-Month Return-18.3%-10.81%-2.39%
1-Year Return-64.12%-7.12%11.69%
3-Year Return-83.93%-0.57%42.29%
5-Year Return-93.24%27.64%93.12%
10-Year Return-89.95%75.45%179.21%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue90.73M25.54M19.71M78.12M32.31M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":28.15,"profit":true},{"date":"2022-12-31","value":21.73,"profit":true},{"date":"2023-12-31","value":86.1,"profit":true},{"date":"2024-12-31","value":35.61,"profit":true}]
Cost of Revenue158.00M5.05M6.34M177.65M5.81M[{"date":"2020-12-31","value":88.94,"profit":true},{"date":"2021-12-31","value":2.84,"profit":true},{"date":"2022-12-31","value":3.57,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":3.27,"profit":true}]
Gross Profit90.73M25.54M19.71M(99.53M)26.50M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":28.15,"profit":true},{"date":"2022-12-31","value":21.73,"profit":true},{"date":"2023-12-31","value":-109.69,"profit":false},{"date":"2024-12-31","value":29.21,"profit":true}]
Gross Margin100.00%100.00%100.00%(127.40%)82.02%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-127.4,"profit":false},{"date":"2024-12-31","value":82.02,"profit":true}]
Operating Expenses225.57M218.69M245.66M247.30M283.47M[{"date":"2020-12-31","value":79.58,"profit":true},{"date":"2021-12-31","value":77.15,"profit":true},{"date":"2022-12-31","value":86.66,"profit":true},{"date":"2023-12-31","value":87.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(134.84M)(193.15M)(225.95M)(169.18M)(238.92M)[{"date":"2020-12-31","value":-13484000000,"profit":false},{"date":"2021-12-31","value":-19314600000,"profit":false},{"date":"2022-12-31","value":-22595000000,"profit":false},{"date":"2023-12-31","value":-16918100000,"profit":false},{"date":"2024-12-31","value":-23892000000,"profit":false}]
Total Non-Operating Income/Expense21.47M2.99M9.74M29.84M15.89M[{"date":"2020-12-31","value":71.93,"profit":true},{"date":"2021-12-31","value":10.01,"profit":true},{"date":"2022-12-31","value":32.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":53.24,"profit":true}]
Pre-Tax Income(115.98M)(192.50M)(220.43M)(153.22M)(237.09M)[{"date":"2020-12-31","value":-11597600000,"profit":false},{"date":"2021-12-31","value":-19250200000,"profit":false},{"date":"2022-12-31","value":-22043200000,"profit":false},{"date":"2023-12-31","value":-15321900000,"profit":false},{"date":"2024-12-31","value":-23709300000,"profit":false}]
Income Taxes(6.56M)(7.39M)(16.08M)5.90M-[{"date":"2020-12-31","value":-111.33,"profit":false},{"date":"2021-12-31","value":-125.42,"profit":false},{"date":"2022-12-31","value":-272.72,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(109.41M)(185.11M)(204.35M)(159.12M)-[{"date":"2020-12-31","value":-10941200000,"profit":false},{"date":"2021-12-31","value":-18510700000,"profit":false},{"date":"2022-12-31","value":-20435200000,"profit":false},{"date":"2023-12-31","value":-15911510500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(115.98M)(192.50M)(220.43M)(195.08M)(237.09M)[{"date":"2020-12-31","value":-11597600000,"profit":false},{"date":"2021-12-31","value":-19250200000,"profit":false},{"date":"2022-12-31","value":-22043200000,"profit":false},{"date":"2023-12-31","value":-19508300000,"profit":false},{"date":"2024-12-31","value":-23709300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(109.41M)(185.11M)(204.35M)(153.22M)(237.09M)[{"date":"2020-12-31","value":-10941200000,"profit":false},{"date":"2021-12-31","value":-18510700000,"profit":false},{"date":"2022-12-31","value":-20435200000,"profit":false},{"date":"2023-12-31","value":-15321900000,"profit":false},{"date":"2024-12-31","value":-23709300000,"profit":false}]
EPS (Diluted)(2.00)(2.85)(3.21)(2.05)(2.88)[{"date":"2020-12-31","value":-200,"profit":false},{"date":"2021-12-31","value":-285,"profit":false},{"date":"2022-12-31","value":-321,"profit":false},{"date":"2023-12-31","value":-205,"profit":false},{"date":"2024-12-31","value":-288,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

EDIT
Cash Ratio 3.02
Current Ratio 3.08

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

EDIT
ROA (LTM) -36.80%
ROE (LTM) -140.82%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

EDIT
Debt Ratio Lower is generally better. Negative is bad. 0.76
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.24

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

EDIT
Trailing PE NM
Forward PE NM
P/S (TTM) 4.27
P/B 2.45
Price/FCF NM
EV/R 1.25
EV/Ebitda NM
PEG NM

FAQs

What is Editas Medicine Inc share price today?

Editas Medicine Inc (EDIT) share price today is $1.83

Can Indians buy Editas Medicine Inc shares?

Yes, Indians can buy shares of Editas Medicine Inc (EDIT) on Vested. To buy Editas Medicine Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EDIT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Editas Medicine Inc be purchased?

Yes, you can purchase fractional shares of Editas Medicine Inc (EDIT) via the Vested app. You can start investing in Editas Medicine Inc (EDIT) with a minimum investment of $1.

How to invest in Editas Medicine Inc shares from India?

You can invest in shares of Editas Medicine Inc (EDIT) via Vested in three simple steps:

  • Click on Sign Up or Invest in EDIT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Editas Medicine Inc shares
What is Editas Medicine Inc 52-week high and low stock price?

The 52-week high price of Editas Medicine Inc (EDIT) is $6.22. The 52-week low price of Editas Medicine Inc (EDIT) is $0.91.

What is Editas Medicine Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Editas Medicine Inc (EDIT) is 2.45

What is the Market Cap of Editas Medicine Inc?

The market capitalization of Editas Medicine Inc (EDIT) is $135.61M

What is Editas Medicine Inc’s stock symbol?

The stock symbol (or ticker) of Editas Medicine Inc is EDIT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top